543 Hospital Acquired Burn Cellulitis in a Single ABA Verified Burn Center
Sylvonne Layne, Kaitlyn Libraro, Abraham Houng

TL;DR
This study reports a 2.4% rate of hospital-acquired burn cellulitis in a burn center, with no clear risk factors identified.
Contribution
The paper provides original data on hospital-acquired burn cellulitis rates and characteristics in a single burn center.
Findings
Hospital-acquired burn cellulitis occurred in 2.4% of patients admitted without prior cellulitis.
Most cases involved lower extremity burns and occurred around day 4.45 of hospitalization.
No clear risk factors or patterns were identified for hospital-acquired burn cellulitis.
Abstract
Cellulitis is a known complication in burn injuries. It is one of the leading infections in burn patients. Risk factors for cellulitis include delay in treatment, history of diabetes and burns that require surgery. The rate of burn cellulitis has been published in numerous studies. However, hospital acquired burn cellulitis is not well known. Through our burn center’s quality improvement program, we examined our institution’s hospital acquired burn cellulitis rate in a given year. Data from weekly quality improvement meeting was used to capture burn patients with cellulitis. Hospital acquired burn cellulitis was defined as patients admitted without cellulitis, but developed cellulitis around the burn wound after 24 hours of admission. Study time ranged from 1/1/2023 to 12/31/2023. Data abstracted included demographics, medical history, injury details and hospital course. In 2023, we…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChemotherapy-related skin toxicity · Burn Injury Management and Outcomes · COVID-19 and healthcare impacts
